Seroreactivity against Epstein-Barr virus (EBV) among first-degree relatives of sporadic EBV-associated nasopharyngeal carcinoma in Indonesia.
about
Therapeutic implications of Epstein-Barr virus infection for the treatment of nasopharyngeal carcinomaEpstein-Barr virus mRNA profiles and viral DNA methylation status in nasopharyngeal brushings from nasopharyngeal carcinoma patients reflect tumor originSeroprevalence of IgA anti Epstein-Barr virus is high among family members of nasopharyngeal cancer patients and individuals presenting with chronic complaints in head and neck area.
P2860
Seroreactivity against Epstein-Barr virus (EBV) among first-degree relatives of sporadic EBV-associated nasopharyngeal carcinoma in Indonesia.
description
2012 nî lūn-bûn
@nan
2012 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Seroreactivity against Epstein ...... yngeal carcinoma in Indonesia.
@ast
Seroreactivity against Epstein ...... yngeal carcinoma in Indonesia.
@en
Seroreactivity against Epstein-Barr virus
@nl
type
label
Seroreactivity against Epstein ...... yngeal carcinoma in Indonesia.
@ast
Seroreactivity against Epstein ...... yngeal carcinoma in Indonesia.
@en
Seroreactivity against Epstein-Barr virus
@nl
prefLabel
Seroreactivity against Epstein ...... yngeal carcinoma in Indonesia.
@ast
Seroreactivity against Epstein ...... yngeal carcinoma in Indonesia.
@en
Seroreactivity against Epstein-Barr virus
@nl
P2093
P2860
P356
P1476
Seroreactivity against Epstein ...... ryngeal carcinoma in Indonesia
@en
P2093
Bambang Hariwiyanto
Baning Rahayu Jati
Camelia Herdini
Jajah Fachiroh
Sofia Mubarika Haryana
Susanna Hilda Hutajulu
P2860
P304
P356
10.1002/JMV.23263
P577
2012-05-01T00:00:00Z